UC Pancreatic Cancer Consortium


clinical trials

Pancreas Cancer Clinical Trials across the UC System

upcoming events

UCPCC Seminar Series

and upcoming Symposia

funding opportunities

Open opportunities are listed below


UCPCC Seminar Series

All seminars are held on the first Tuesday of each month from 8:00-9:00 AM PT. 

February 1, 2022 8:00-9:00 AM

Speaker: Jonathan Brody (Oregon Health & Science University)

Alternative Approaches to Targeting the Resistant Phenotype of Pancreatic Cancer

Join the meeting using this link

March 1, 2022 8:00-9:00 AM

Speaker: Roland Rad (Technical University of Munich)

Join the meeting using this link

April 5, 2022 8:00-9:00 AM

Speaker: Adrienne Cox (University of North Carolina)

Join the meeting using this link

May 3, 2022 8:00-9:00 AM

Speaker: Marina Pasca di Magliano (University of Michigan)

Join the meeting using this link

June 7, 2022 8:00-9:00 AM

Speaker: Ron Evans (Salk Institute)

Join the meeting using this link

July 5, 2022 8:00-9:00 AM

Speaker: Anirban Maitra (MD Anderson)

Join the meeting using this link

August 2, 2022 8:00-9:00 AM

Speaker: Anindya Bagachi (Sanford Burnham Prebys)

Join the meeting using this link

September 6, 2022 8:00-9:00 AM

Speaker: Shweta Joshi (UC San Diego)

Join the meeting using this link

October 4, 2022 8:00-9:00 AM

Speaker: Elizabeth Jaffee (Johns Hopkins)

Turning the Heat Up on Pancreatic Cancer: Lessons on Overcoming a “Cold” Immunologic Tumor Micro-environment

Join the meeting using this link


Who We Are

The mission of the UC Pancreatic Cancer Consortium (UCPCC) is to unite scientists and clinicians across the UC cancer centers committed to pancreatic cancer research and treatment in a highly collaborative environment that accelerates the progress and impact of our work.

Our vision is to improve the lives of persons diagnosed with pancreatic cancer by translating innovative research into improved clinical care.

UCPCC UC Leaders: 
UC Davis Comprehensive Cancer Center – Richard Bold
UCI Chao Family Comprehensive Cancer Center – Murray Korc
UCLA Jonsson Comprehensive Cancer Center – Timothy Donahue
UC San Diego Moores Cancer Center – Andrew Lowy
UCSF Helen Diller Family Comprehensive Cancer Center – Margaret Tempero






Left to right; Dr’s Richard Bold, Andrew Lowy, Margaret Tempero, Tannishtha Reya, Julie Sutcliffe and Katie Couric at the Stand Up To Cancer 2019 Scientific Summit in Santa Monica, CA.

UC Pancreatic Cancer Consortium Working Groups:


  • Biobanking

  • Early Biology                                         

  • Early Detection

  • Imaging                                  

  • Inherited Susceptibility  

  • PDAC Clinical Trials

  • Technology Assessment

  • PNET

Funding Opportunities

The UC Pancreatic Cancer Consortium will fund a one-year pilot to encourage collaboration between UC campuses, with the expectation that it will lead to submission of a major collaborative grant such as an NIH P01, multi-PI R01, or similar. One award will be given up to $150,000.


Applications for this cycle are due at 5pm PT on March 1, 2022. Please refer to the Request for Applications for full details:

Spring 2022 Request for Applications (pdf)


For additional information or guidance, contact Kurt Giles (kurt.giles@ucsf.edu).

Pilot Awards:

  • 2021

    • Germline Testing in Pancreatic Neuroendocrine Tumors: Mallika Dhawan and Emily Bergsland (UCSF), Joel (Randy) Hecht (UCLA), and Andrew Lowy (UCSD)

    • Defining the metabolic vulnerabilities of chemoresistant pancreatic cancer: Christopher Halbrook (UCI) and Herve Tiriac (UCSD)


Copyright 2021 © Regents of the University of California